Pharmacotherapy of glaucoma

D Schmidl, L Schmetterer, G Garhöfer… - Journal of Ocular …, 2015 - liebertpub.com
Glaucoma is a group of diseases involving the optic nerve and associated structures, which
is characterized by progressive visual field loss and typical changes of the optic nerve head …

Glaucoma management: relative value and place in therapy of available drug treatments

D Sambhara, AA Aref - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Lowering intraocular pressure (IOP) is the only proven therapeutic intervention for
glaucomatous optic neuropathy. Despite advances in laser and microsurgical techniques …

Management of glaucoma: focus on pharmacological therapy

RE Marquis, JT Whitson - Drugs & aging, 2005 - Springer
Glaucoma represents a major cause of vision loss throughout the world. Primary open-angle
glaucoma, the most common form of glaucoma, is a chronic, progressive disease often …

Current medical therapy and future trends in the management of glaucoma treatment

B Cvenkel, M Kolko - Journal of Ophthalmology, 2020 - Wiley Online Library
Glaucoma is a neurodegenerative disease characterized by progressive loss of retinal
ganglion cells and their axons. Lowering of intraocular pressure (IOP) is currently the only …

Current situation and progress of drugs for reducing intraocular pressure

P Liu, F Wang, Y Song, M Wang… - … advances in chronic …, 2022 - journals.sagepub.com
Glaucoma, the most common cause of irreversible blindness worldwide, usually causes
characteristic optic nerve damage. Pathological intraocular pressure (IOP) elevation is a …

The latest drugs in development that reduce intraocular pressure in ocular hypertension and glaucoma

V Jayanetti, S Sandhu, JA Lusthaus - Journal of Experimental …, 2020 - Taylor & Francis
Glaucoma causes irreversible vision loss, with elevated intraocular pressure (IOP) being the
only known modifiable risk factor. There are a variety of medical and interventional options …

Therapy for open-angle glaucoma

LL Marshall, RL Hayslett… - The Consultant …, 2018 - ingentaconnect.com
Therapy for Open-Angle Glaucoma Page 1 432 THE CONSULTANT PHARMACIST AUGUST
2018 VOL. 33, NO. 8 Clinical Review Therapy for Open-Angle Glaucoma Leisa L. Marshall …

Changing paradigms in the medical treatment of glaucoma

JB Soltau, TJ Zimmerman - Survey of Ophthalmology, 2002 - Elsevier
Glaucoma is defined by a typical optic neuropathy accompanied by characteristic visual field
loss and eventual blindness. The major risk factor for glaucoma is elevated intraocular …

Current and new pharmacotherapeutic approaches for glaucoma

WS Shalaby, V Shankar, R Razeghinejad… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Glaucoma is the leading cause of irreversible blindness worldwide. Medical
therapy is the main line of treatment of open-angle glaucoma (OAG) and ocular …

The management of glaucoma and intraocular hypertension: current approaches and recent advances

RJ Noecker - Therapeutics and clinical risk management, 2006 - Taylor & Francis
In the last decade, numerous novel ocular hypotensive agents have been introduced for the
control of intraocular pressure (IOP). Clinicians now have more options than ever in the …